Bevacizumab 25 mg/ml
Concentrate for solution for infusion
Image
Product Description
- Bevasan contains the active substance bevacizumab, which is a humanised monoclonal antibody (a type of protein that is normally made by the immune system to help defend the body from infection and cancer).
- Bevasan is used for the treatment of adult patients with:
- Advanced cancer in the large bowel, i.e., in the colon or rectum.
- Metastatic breast cancer.
- Advanced non-small cell lung cancer.
- Advanced kidney cancer.
- Advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer